Recent Publications

The journal articles below are recent publications authored or co-authored by VSPB staff.

Publications by Year

2020

Amman BR, Schuh AJ, Sealy TK, et al. Experimental infection of Egyptian rousette bats (Rousettus aegyptiacus) with Sosuga virus demonstrates potential transmission routes for a bat-borne human pathogenic paramyxovirusexternal icon. PLoS Negl Trop Dis. 2020 Mar 2;14(3):e0008092.

Lee KH, Nikolay B, Sazzad HMS, et al. Changing contact patterns over disease progression: Nipah virus as a case studyexternal icon. J Infect Dis. 2020 Mar 2:jiaa091.

Lo MK, Amblard F, Flint M, et al. Potent in vitro activity of β-D-4′-chloromethyl-2′-deoxy-2′-fluorocytidine against Nipah virusexternal icon. Antiviral Res. 2020 Mar;175:104712.

Welch SR, Tilston NL, Lo MK, et al. Inhibition of Nipah Virus by Defective Interfering Particlesexternal icon. J Infect Dis. 2020 Feb 28:jiz564.

Wozniak DM, Lavender KJ, Prescott J, Spengler JR. The Utility of Human Immune System Mice for High-Containment Viral Hemorrhagic Fever Researchexternal icon. Vaccines (Basel). 2020 Feb 22;8(1):E98.

Reichler MR, Bruden D, Thomas H. Ebola Patient Virus Cycle Threshold and Risk of Household Transmission of Ebola Virusexternal icon. J Infect Dis. 2020 Feb 18;221(5):707-714.

Lo MK, Spengler JR, Krumpe LRH, et al. Griffithsin Inhibits Nipah Virus Entry and Fusion and Can Protect Syrian Golden Hamsters From Lethal Nipah Virus Challengeexternal icon. J Infect Dis. 2020 Feb 10:jiz630.

Zivcec M, Spiropoulou CF, Spengler JR. The use of mice lacking type I or both type I and type II interferon responses in research on hemorrhagic fever viruses. Part 2: Vaccine efficacy studiesexternal icon. Antiviral Res. 2020 Feb;174:104702.

McMullan LK. Clinical trials in an Ebola outbreak seek to find an evidence-based cureexternal icon. EBioMedicine. 2020 Feb;52:102614.

Amman BR, Bird BH, Bakarr IA, et al. Isolation of Angola-like Marburg virus from Egyptian rousette bats from West Africaexternal icon. Nat Commun. 2020 Jan 24;11(1):510.